Date: March 1-4, 2020
Location: Moscone South Convention Center, San Francisco, CA
Blood and Urine-based Liquid Biopsy Solutions for TMB and MRD in Clinical Trials
In this talk, we’ll present the development and clinical applications of blood and urine-based liquid biopsy solutions using cfDNA and cfRNA. Case studies for cfDNA-based TMB and MRD profiling, cfRNA-based splicing and fusion profiling, and clinical lab solutions for global trials will be discussed.
Time: Tuesday, March 3, 2020 | 11:55am
Speaker: Shidong Jia, PhD, MD | Founder and CEO | Predicine